The U.S. FDA has granted Fast Track designation to ProMIS Neurosciences’ (ProMIS Neurosciences Stock Quote, Chart, News, Analysts, Financials NASDAQ:PMN) Alzheimer’s candidate PMN310, sending the company’s shares up more than 150% on July 21. The stock closed at US$1.12, up from US$0.44, after peaking at US$1.38 earlier in the session. Leede Financial analyst Douglas Loe […]
Cresco Labs (Cresco Labs Stock Quote, Chart, News, Analysts, Financials CSE:CL) has announced plans to withdraw from the California market, citing structural challenges as it continues its focus on margin improvement and financial health. Following the announcement, Roth Capital Markets analyst Bill Kirk maintained a “Buy” rating and $2.00 target in a July 21 note, […]
Share
Tweet
Share
